HI SB3094 | 2018 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on January 24 2018 - 25% progression, died in committee
Action: 2018-02-22 - The committee on CPH deferred the measure.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Specifies certain activities that shall become lawful, upon approval by the federal Food and Drug Administration of one or more prescription drugs containing cannabidiol.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To Prescription Drugs Containing Cannabidiol.

Sponsors


History

DateChamberAction
2018-02-22SenateThe committee on CPH deferred the measure.
2018-02-22SenateThe committee on JDC deferred the measure.
2018-02-20SenateThe committee(s) on CPH/JDC added the measure to the public hearing scheduled on 02-22-18 9:00AM in conference room 229.
2018-02-20SenateRe-Referred to CPH/JDC.
2018-01-26SenateReferred to PSM/CPH, JDC.
2018-01-26SenatePassed First Reading.
2018-01-24SenateIntroduced.

Subjects


Hawaii State Sources


Bill Comments

feedback